Pharma Research Products Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
5,662
8,838
12,878
13,827
12,517
Depreciation, Depletion & Amortization
415
762
1,031
1,143
1,306
Funds from Operations
7,107
11,016
16,240
13,447
17,799
Changes in Working Capital
2,042
2,175
217
5,286
9,156
Net Operating Cash Flow
5,065
8,840
16,023
8,161
8,643
Capital Expenditures
3,868
13,616
463
1,958
6,874
Sale of Fixed Assets & Businesses
-
5
8
6
3,001
Purchase/Sale of Investments
1,020
1,824
118,656
1,960
3,751
Net Investing Cash Flow
2,608
15,436
119,111
1,018
3,056
Cash Dividends Paid - Total
-
-
-
1,893
2,820
Issuance/Reduction of Debt, Net
1,617
7,500
5,500
-
-
Net Financing Cash Flow
1,617
8,500
108,065
4,577
5,698
Net Change in Cash
4,074
1,905
4,973
2,771
644
Free Cash Flow
1,708
3,864
15,673
6,783
1,891
Net Assets from Acquisitions
-
-
-
1,083
-
Other Sources
240
-
-
166
96
Change in Capital Stock
-
1,000
113,565
2,684
2,303
Exchange Rate Effect
-
-
4
205
533
Other Uses
-
-
-
109
3,030
About Pharma Research Products Co.
View Profile
